iNtRON Biotechnology, Inc. (KOSDAQ: 048530)

iNtRON Biotechnology Revenue

iNtRON Biotechnology had revenue of 1.21B KRW in the quarter ending September 30, 2024, a decrease of -27.70%. This brings the company's revenue in the last twelve months to 8.61B, up 3.77% year-over-year. In the year 2023, iNtRON Biotechnology had annual revenue of 9.59B, down -31.57%.

• Revenue (ttm): 8.61B
• Revenue Growth: +3.77%
• P/S Ratio: 20.70
• Revenue / Employee: 113.35M
• Employees: 76
• Market Cap: 176.36B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	9.59B	-4.42B	-31.57%
Dec 31, 2022	14.01B	-15.30B	-52.21%
Dec 31, 2021	29.31B	-16.13B	-35.49%
Dec 31, 2020	45.43B	37.09B	444.28%
Dec 31, 2019	8.35B	-12.24B	-59.45%